![Life | Free Full-Text | Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach Life | Free Full-Text | Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach](https://www.mdpi.com/life/life-12-00383/article_deploy/html/images/life-12-00383-g001.png)
Life | Free Full-Text | Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach
![Cancers | Free Full-Text | Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients Cancers | Free Full-Text | Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients](https://pub.mdpi-res.com/cancers/cancers-14-01849/article_deploy/html/images/cancers-14-01849-ag.png?1649396742)
Cancers | Free Full-Text | Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients
![Огромен напредък в лечението на раковите заболявания през 2012 година - ФОРУМ ЗДРАВЕ | Порталът за по-здравословен живот Огромен напредък в лечението на раковите заболявания през 2012 година - ФОРУМ ЗДРАВЕ | Порталът за по-здравословен живот](https://forumzdrave.bg/wp-content/uploads/2012/12/medicine-848503_1280-730x486.jpg)
Огромен напредък в лечението на раковите заболявания през 2012 година - ФОРУМ ЗДРАВЕ | Порталът за по-здравословен живот
![IJMS | Free Full-Text | A Novel Paclitaxel Conjugate with Higher Efficiency and Lower Toxicity: A New Drug Candidate for Cancer Treatment IJMS | Free Full-Text | A Novel Paclitaxel Conjugate with Higher Efficiency and Lower Toxicity: A New Drug Candidate for Cancer Treatment](https://www.mdpi.com/ijms/ijms-20-04965/article_deploy/html/images/ijms-20-04965-g004.png)
IJMS | Free Full-Text | A Novel Paclitaxel Conjugate with Higher Efficiency and Lower Toxicity: A New Drug Candidate for Cancer Treatment
![Frontiers | Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel Frontiers | Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel](https://www.frontiersin.org/files/Articles/1157306/fphar-14-1157306-HTML/image_m/fphar-14-1157306-g001.jpg)
Frontiers | Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel
![Cancers | Free Full-Text | Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment? Cancers | Free Full-Text | Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?](https://www.mdpi.com/cancers/cancers-15-00689/article_deploy/html/images/cancers-15-00689-g001-550.jpg)
Cancers | Free Full-Text | Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
![IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer](https://www.mdpi.com/ijerph/ijerph-17-02213/article_deploy/html/images/ijerph-17-02213-g001.png)
IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
![Паклитаксел и его новые возможности при лечении больных раком яичников | Блюменберг А.Г. | «РМЖ» №11 от 03.06.2003 Паклитаксел и его новые возможности при лечении больных раком яичников | Блюменберг А.Г. | «РМЖ» №11 от 03.06.2003](https://www.rmj.ru/data/articles/Image/t11/n11/t650.gif)
Паклитаксел и его новые возможности при лечении больных раком яичников | Блюменберг А.Г. | «РМЖ» №11 от 03.06.2003
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Single Technology Appraisal (STA) Pembrolizumab for untreated PD-L1 positive n
![IJMS | Free Full-Text | In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and IJMS | Free Full-Text | In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and](https://pub.mdpi-res.com/ijms/ijms-22-03019/article_deploy/html/images/ijms-22-03019-ag.png?1615891370)
IJMS | Free Full-Text | In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and
![Clinics and Practice | Free Full-Text | Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports Clinics and Practice | Free Full-Text | Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports](https://pub.mdpi-res.com/clinpract/clinpract-13-00018/article_deploy/html/images/clinpract-13-00018-g001-550.jpg?1675078276)
Clinics and Practice | Free Full-Text | Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports
![Frontiers | Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer Frontiers | Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer](https://www.frontiersin.org/files/Articles/666691/fonc-11-666691-HTML-r1/image_m/fonc-11-666691-g001.jpg)
Frontiers | Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer
![Ролята на индивидуалните генетични характеристики за ефективността на лечение с Паклитаксел - NMGenomix – Персонализирана Медицина Ролята на индивидуалните генетични характеристики за ефективността на лечение с Паклитаксел - NMGenomix – Персонализирана Медицина](https://nmgenomix.com/wp-content/uploads/2018/09/22years.jpg)
Ролята на индивидуалните генетични характеристики за ефективността на лечение с Паклитаксел - NMGenomix – Персонализирана Медицина
![Frontiers | Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen Frontiers | Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen](https://www.frontiersin.org/files/MyHome%20Article%20Library/1027515/1027515_Thumb_400.jpg)
Frontiers | Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen
![Frontiers | Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein Frontiers | Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein](https://www.frontiersin.org/files/Articles/752127/fonc-11-752127-HTML-r2/image_m/fonc-11-752127-g001.jpg)
Frontiers | Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein
![Frontiers | Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review Frontiers | Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review](https://www.frontiersin.org/files/Articles/770663/fphar-12-770663-HTML-r1/image_m/fphar-12-770663-g001.jpg)
Frontiers | Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
![A trial comparing two combinations of chemotherapy for clear cell ovarian cancer (CCC1) | Cancer Research UK A trial comparing two combinations of chemotherapy for clear cell ovarian cancer (CCC1) | Cancer Research UK](https://www.cancerresearchuk.org/sites/default/files/styles/cruk_wide_resp_breakpoint_one/public/diagram_showing_ccc1_randomisation_results.png?itok=L_RLFUVO)